Eosinophil peroxidase: A new serum marker of atopy and bronchial hyper-responsiveness

Respiratory Medicine

Volumn 90, Issue 1, 1996, Pages 39-46

  Bjornsson E ^a,b,c   Janson, C ^a,c   Hakansson L ^a,c   Enander, I ^d   Venge, P ^b,c   Boman, G ^a,c  

^a Department of Lung Medicine ^*  (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; MARKER; PEROXIDASE;

ADULT; ARTICLE; ASTHMA; ATOPY; BLOOD LEVEL; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERUM; SWEDEN;

EID: 0029972487     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90243-7     Document Type: Article

References (32)

1. Cookson WOCM, Craddock CF, Benson MK, Durham SR. Falls in peripheral eosinophil counts parallel the late asthmatic response. Am Rev Respir Dis 1989; 139: 458-462.
2. Venge P, Håkansson L. Current understanding of the role of the eosinophil granulocyte in asthma. Clin Exp Allergy 1991; 21 (suppl.): 31-37.
3. Horn BR, Robin ED, Theodore J, VanKessel A. Total eosinophilia counts in the management of bronchial asthma. N Eng J Med 1975; 292: 1152-1155.
4. Taylor KJ, Luksza AR. Peripheral blood eosinophil counts and bronchial responsiveness. Thorax 1987; 42: 452-456.
5. Venge P, Dahl R, Peterson CGB. Eosinophil granule proteins in serum after allergen challange of asthmatic patients and the effects of anti-asthmatic medication, Int Arch All Appl Immunol 1988; 87: 306-312.
6. Björnsson E, Janson C, Hâkansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1994; 49: 730-736.
7. Sugai T, Sakiyama Y, Matumoto S. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases. Clin Exp All 1992; 22: 275-281.
8. Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CGB, Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp All 1993; 23: 564-570.
9. Griffin E, Håkansson L, Formgren H, Jörgensen K, Peterson C, Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991; 87: 548-557.
10. Rak S, Lövhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients. J Allergy Clin Immunol 1988; 82: 470-480.
11. Carlson M, Håkansson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J All Clin Immunol 1991; 87: 27-33.
12. Khalife J, Capron M, Cesbron JY et al. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J Immunol 1986; 137: 1659-1664.
13. Tomassini M, Tsicopoulos A, Tai PC et al. Release of granule proteins by eosinophils from allergic and non-allergic patients with eosinophilia on immunoglobulin-dependent activation. J All Clin Immunol 1991; 88: 365-375.
14. Karawajczyk M, Pauksens K, Venge P. The differential release of eosinophil granule proteins in vitro and in vivo. Studies on patients with acute bacterial and viral infections. Submitted.
15. Burney PGJ, Luczynska CM, Chinn S, Jarvis D. The European community respiratory health survey. Eur Respir J 1994; 7: 954-960.
16. European Community for Coal and Steel. Standardization of lung function tests. Clin Resp Phys 1983; 19 (suppl. 5): 22-27.
17. Higgins BG, Britton JR, Chinn S, Cooper S, Burney PGJ, Tattersfleld AE. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiological studies. Am Rev Respir Dis 1992; 145: 588-93.
18. Knox AJ, Wisniewski A, Cooper S, Tattersfleld AE. A comparison of the Yan and a dosimeter method for methacholine challenge in experienced and inexperienced subjects. Eur Resp J 1991; 4: 497-502.
19. Peterson CGB, Enander I, Nystrand J, Andersson AS, Nilson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp All 1991; 21: 561-567.
20. Burney PGJ, Laitinen EA, Perdrizet S et al. Validity and repeatability of the IUATED (1984) bronchial symptoms questionnaire: an international comparison. Eur Resp J 1989; 2: 940-945.
21. BPGJ, Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987; 91 (suppl.): 79-92.
22. Dreborg S. (ed.) Skin tests used for epidemiological studies. Allergy 1989; 44 (suppl.): 52-59.
23. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage of respiratory epithelium: A model for bronchial hyperreactivity. J All Clin Immunol 1988; 81: 776-781.
24. Beasley R, Coleman ED, Hermon Y, Holst PE, ODonnell TV, Tobias M. Viral respiatory tract infection and exacerbations of asthma in adult patients. Thorax 1988; 43: 679-683.
25. Kroegel C, Warner JA, Virchow JC, Mattys H. Pulmonary immune cells in health and disease: the eosinophil leucocyte (part II). Eur Resp J 1994 ; 7: 519-543.
26. Colins DS, Dupuis R, Gleich GJ et al. Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am Rev Resp Dis 1993; 147: 677-683.
27. Yoshikawa S, Kayes SG, Parker JC. Eosinophils increase lung microvascular permeability via the peroxidase-hydrogen peroxide-halide system. Am Rev Resp Dis 1993; 147: 914-920.
28. Motojima S, Fukuda T, Makino S. Effect of eosinophil peroxidase on beta-adrenergic receptor density on guinea pig lumg membrane. Biochem Biophys Res Commun 1992; 189: 1613-1619.
29. Carlson M. Eosinophil Granule Proteins and the Mechanism of their Secretion. Thesis Uppsala University, 1992
30. Kita H, Abu-Ghazelah RI, Gleich GJ, Abraham RT. Role of pertussis toxin-sensitive G proteins in stimulusdependant human eosinophil degranulation. J All Clin Immunol 1991; 87: 70-77.
31. Winqvist I, Olofssonh T, Olsson I. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunol 1984; 51: 1-8.
32. Kita H, Abu-Ghazelah RI, Sanderson CJ, Gleich GJ. Effects of steroids on immunoglobulin-induced eosinophil degranulation. J Immunol 1991; 147: 3466-3473.